Correspondence 0001839998-23-000010 from American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)
American Oncology Network, Inc. (AONC, AONCW) (CIK 0001839998)
Date: Dec. 4, 2023 · CIK: 0001839998 · Accession: 0001839998-23-000010
AI Filing Summary & Sentiment
File numbers found in text: 333-274975
Letter
Document
AMERICAN ONCOLOGY NETWORK, INC.
14543 Global Parkway, Suite 110
Fort Myers, FL 33913
Telephone: (833) 886-1725
December 4, 2023
Via EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, DC 20549-3010
Attn: Nicholas O’ Leary
Re: American Oncology Network, Inc. Registration Statement on Form S-1 File No. 333-274975 Acceleration Request Requested Date: December 6, 2023 Requested Time: 4:30 P.M. Eastern Time (or as soon thereafter as possible)
Ladies and Gentlemen:
American Oncology Network, Inc. (the “Company”), pursuant to Rule 461 under the Securities Act of 1933, as amended, hereby requests that the above-referenced Registration Statement on Form S-1 be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel, Dentons US LLP, may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”).
Once the Registration Statement has been declared effective, please orally confirm that event with Brian Lee of Dentons US LLP, counsel to the Company, at (212) 768 6926.
Sincerely,
AMERICAN ONCOLOGY NETWORK, INC.
Show Raw Text
CORRESP 1 filename1.htm Document AMERICAN ONCOLOGY NETWORK, INC. 14543 Global Parkway, Suite 110 Fort Myers, FL 33913 Telephone: (833) 886-1725 December 4, 2023 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, DC 20549-3010 Attn: Nicholas O’ Leary Re: American Oncology Network, Inc. Registration Statement on Form S-1 File No. 333-274975 Acceleration Request Requested Date: December 6, 2023 Requested Time: 4:30 P.M. Eastern Time (or as soon thereafter as possible) Ladies and Gentlemen: American Oncology Network, Inc. (the “Company”), pursuant to Rule 461 under the Securities Act of 1933, as amended, hereby requests that the above-referenced Registration Statement on Form S-1 be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel, Dentons US LLP, may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with Brian Lee of Dentons US LLP, counsel to the Company, at (212) 768 6926. Sincerely, AMERICAN ONCOLOGY NETWORK, INC. By: /s/ Todd Schonherz Name: Todd Schonherz Title: Chief Executive Officer cc: Brian Lee, Esq. Dentons US LLP